At a glance
ClinicalIndex Comparison RecordN/ACompleted· 173 enrolled
Drug / intervention
Coin2Dosebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Coin2Dose: Behavioral Economics to Promote Insulin BOLUS Activity and Improve HbA1c in Teens
In Brief
A clinical study evaluating Coin2Dose for Type 1 Diabetes. Completed, enrolled 173 participants across 2 sites.
Detailed Summary
Our objective is to test the feasibility, acceptability, and initial efficacy of using behavioral economics incentives (BEI) in a novel, semi-automated intervention to target daily insulin BOLUS scores in adolescents with suboptimal insulin use.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2023202420252026
First PostedMar 2022
Enrollment StartJan 2023
Primary CompletionJun 2025
Study CompletionSep 2025
TodayJul 2026
First PostedMar 15, 2022
Enrollment StartJan 1, 2023
Primary CompletionJun 30, 2025
Study CompletionSep 30, 2025
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 4.3 years ago
Interventions
Coin2Dosebehavioral
Behavioral Economics incentive intervention that also combines automated text message reminders to dose for insulin